PBA

Paradigm Biocapital Advisors Portfolio holdings

AUM $2.34B
This Quarter Return
+19.03%
1 Year Return
+13.3%
3 Year Return
+245.82%
5 Year Return
–
10 Year Return
–
AUM
$1.24B
AUM Growth
+$181M
Cap. Flow
+$133M
Cap. Flow %
10.76%
Top 10 Hldgs %
56.62%
Holding
34
New
9
Increased
17
Reduced
3
Closed
5

Top Buys

1
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
$61.5M
2
NUVL icon
Nuvalent
NUVL
$47.3M
3
AMAM
Ambrx Biopharma, Inc. Common Stock
AMAM
$27.2M
4
VIR icon
Vir Biotechnology
VIR
$24.9M
5
IMTX icon
Immatics
IMTX
$22.9M

Top Sells

1
BIIB icon
Biogen
BIIB
$97.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
$57.1M
3
KROS icon
Keros Therapeutics
KROS
$39.7M
4
ASND icon
Ascendis Pharma
ASND
$37.6M
5
ARGX icon
argenx
ARGX
$15.2M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
VRNA
26
Verona Pharma
VRNA
$9.18B
$18.9M 1.46%
893,861
-68,500
-7% -$1.45M
MLTX icon
27
MoonLake Immunotherapeutics
MLTX
$3.72B
$18.9M 1.46%
+369,615
New +$18.9M
THRX
28
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
$18.2M 1.41%
1,950,327
+445,000
+30% +$4.15M
KURA icon
29
Kura Oncology
KURA
$719M
$10.6M 0.82%
+1,004,908
New +$10.6M
ASND icon
30
Ascendis Pharma
ASND
$12B
– –
-350,866
Closed -$37.6M
BIIB icon
31
Biogen
BIIB
$20.7B
– –
-349,593
Closed -$97.2M
KROS icon
32
Keros Therapeutics
KROS
$632M
– –
-930,752
Closed -$39.7M
PSTX
33
DELISTED
Poseida Therapeutics, Inc. Common Stock
PSTX
– –
-1,072,410
Closed -$3.3M
SGEN
34
DELISTED
Seagen Inc. Common Stock
SGEN
– –
-281,969
Closed -$57.1M
1
2